Re: “Amantadine for Treatment of Disruptive Mood Dysregulation Disorder Symptoms” by Rice T et al.-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Re: “Amantadine for Treatment of Disruptive Mood Dysregulation Disorder Symptoms” by Rice T et al.

Published:2020-10-01 Issue:8 Volume:30 Page:531-532
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Yoder Rachel¹²,Hulvershorn Leslie¹²³,Ott Carol¹⁴⁵,Minshawi-Patterson Noha¹

Affiliation:

1. Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, USA.

2. Indiana University Health, Indianapolis, Indiana, USA.

3. Indiana Family and Social Services Administration, Indianapolis, Indiana, USA.

4. Purdue University College of Pharmacy, West Lafayette, Indiana, USA.

5. Eskenazi Health, Indianapolis, Indiana, USA.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology and Child Health

Link

https://www.liebertpub.com/doi/pdf/10.1089/cap.2020.0022

Reference5 articles.

1. Possible Oxcarbazepine Inductive Effects on Aripiprazole Metabolism: A Case Report

2. Anticonvulsant Medications and the Risk of Suicide, Attempted Suicide, or Violent Death

3. Amantadine for Treatment of Disruptive Mood Dysregulation Disorder Symptoms

4. Clinical Considerations Related to the Behavioral Manifestations of Child Maltreatment

5. Developmental Changes in Pharmacokinetics and Pharmacodynamics

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP